Cargando…
TMEM43-S358L mutation enhances NF-κB-TGFβ signal cascade in arrhythmogenic right ventricular dysplasia/cardiomyopathy
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a genetic cardiac muscle disease that accounts for approximately 30% sudden cardiac death in young adults. The Ser358Leu mutation of transmembrane protein 43 (TMEM43) was commonly identified in the patients of highly lethal and fu...
Autores principales: | Zheng, Guoxing, Jiang, Changying, Li, Yulin, Yang, Dandan, Ma, Youcai, Zhang, Bing, Li, Xuan, Zhang, Pei, Hu, Xiaoyu, Zhao, Xueqiang, Du, Jie, Lin, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Higher Education Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340891/ https://www.ncbi.nlm.nih.gov/pubmed/29980933 http://dx.doi.org/10.1007/s13238-018-0563-2 |
Ejemplares similares
-
Functional effects of the TMEM43 Ser358Leu mutation in the pathogenesis of arrhythmogenic right ventricular cardiomyopathy
por: Rajkumar, Revathi, et al.
Publicado: (2012) -
TMEM43 Mutation p.S358L Alters Intercalated Disc Protein Expression and Reduces Conduction Velocity in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Siragam, Vinayakumar, et al.
Publicado: (2014) -
Failure of ICD therapy in lethal arrhythmogenic right ventricular
cardiomyopathy type 5 caused by the TMEM43 p.Ser358Leu
mutation
por: Aalbæk Kjærgaard, Kasper, et al.
Publicado: (2016) -
A Drosophila melanogaster model for TMEM43-related arrhythmogenic right ventricular cardiomyopathy type 5
por: Klinke, Nora, et al.
Publicado: (2022) -
Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
por: Indik, Julia H, et al.
Publicado: (2003)